Evidence map›Paper›PMID 24859383›Full record

ArticleMolecular neurobiology2015

Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.

Jin Han Nam, Eunju Leem, Min-Tae Jeon, Kyoung Hoon Jeong, Jeen-Woo Park, Un Ju Jung, Nikolai Kholodilov, Robert E Burke, Byung Kwan Jin, Sang Ryong Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Dioscin-Mediated Autophagy Alleviates MPPMolecules (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Glial cells in Parkinson´s disease: protective or deleterious?Cellular and molecular life sciences : CMLS · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jin Han NamDepartment of Neuroscience, Neurodegeneration Control Research Center, School of Medicine, Kyung Hee University, Seoul, 130-701, Korea.
Eunju Leem
Min-Tae Jeon
Kyoung Hoon Jeong
Jeen-Woo Park
Un Ju Jung
Nikolai Kholodilov
Robert E Burke
Byung Kwan Jin
Sang Ryong Kim
Kyungpook National University · KRColumbia University · USKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transduction of dopaminergic (DA) neurons with human ras homolog enriched in brain, which has a S16H mutation [hRheb(S16H)] protects the nigrostriatal DA projection in the 6-hydroxydopamine (6-OHDA)-treated animal model of Parkinson's disease (PD). However, it is still unclear whether the expression of active hRheb induces the production of neurotrophic factors such as glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), which are involved in neuroprotection, in mature neurons. Here, we show that transduction of nigral DA neurons with hRheb(S16H) significantly increases the levels of phospho-cyclic adenosine monophosphate (cAMP) response element-binding protein (p-CREB), GDNF, and BDNF in neurons, which are attenuated by rapamycin, a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1). Moreover, treatment with specific neutralizing antibodies for GDNF and BDNF reduced the protective effects of hRheb(S16H) against 1-methyl-4-phenylpyridinium (MPP(+))-induced neurotoxicity. These results show that activation of hRheb/mTORC1 signaling pathway could impart to DA neurons the important ability to continuously produce GDNF and BDNF as therapeutic agents against PD.

Indexed as

Disease Models, AnimalAnimalsBrain-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic FactorHumansMonomeric GTP-Binding ProteinsNeuronsNeuropeptidesNeuroprotective AgentsParkinson DiseaseRas Homolog Enriched in Brain ProteinRatsRats, Sprague-DawleySubstantia NigraBrain-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic FactorMonomeric GTP-Binding ProteinsNeuropeptidesNeuroprotective AgentsRas Homolog Enriched in Brain ProteinRHEB protein, human

Identifiers

PMID24859383
OpenAlexW2083475861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.